0 CHECKOUT

PRODUCT FILTERS

REGION

5
1
1
1

COUNTRY

1

CATEGORIES

  • 4
  • 3
  • 2
  • 1
  • 1
  • 1

PRICE

1
1
3
9

PUBLISHED

0
0
1
9

PRODUCT TYPE

8
1

Search for: "Non-Small Cell Lung Cancer - Avastin to Lead the Market"

9 Products

Global & USA Cancer Immunotherapy Market Analysis to 2020

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR)...

Published:  April 2015
Price:  From

Oncology Research Digest H1 2014

The Oncology Research Digest is a digest of all the most important research in the oncology market each quarter It covers areas such as biosimilars, novel immunotherapies, non-small cell lung cancer,...

Published:  August 2014
Price:  From

AVEO Pharmaceuticals’ and Astellas Pharma’s Tivozanib - Can this angiogenesis inhibitor distinguish itself from the field?

Tivozanib is a small molecule VEGF receptor inhibitor in phase III development for renal cell carcinoma (RCC), developed by AVEO Pharmaceuticals and recently partnered with Astellas Pharma It will not...

Published:  July 2011
Price:  From

Cancer Therapies - Global Strategic Business Report

This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy The report provides...

Published:  October 2011
Price:  From

Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities

In a market currently valued around US$42 billion, cancer chemotherapies are on course for staggering growth potential and may revolutionize cancer treatments over the next 10 years according to a new...

Published:  April 2006
Price:  From

Angiogenesis Inhibitors and Stimulators - Global Business Strategic Report

This report analyzes the worldwide markets for Angiogenesis Inhibitors and Stimulators in US$ Million by the following Product Segments: Angiogenesis Inhibitors, and Angiogenesis Stimulators Annual...

Published:  May 2012
Price:  From

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer...

Published:  June 2013
Price:  From

Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success

This is a unique and unrivalled 367-page report analysing the performance of numerous important early stage oncology drug candidates, assessing their market viability based on preclinical scientific...

Published:  November 2006
Price:  From

Idera Pharmaceuticals, Inc. - Product Pipeline Review - 2012

Idera Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Idera Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on...

Published:  August 2012
Price:  From
Loading Indicator

Our Clients

  • Abbott Laboratories Ltd.
  • Ford Motor Company
  • Honeywell International, Inc.
  • Nike, Inc.
  • Deloitte LLP.
  • IMAX Corporation